MA29684B1
Spiro-oxindole compounds and their uses as therapeutic agents
Abstract
The invention relates to spiro-oxindole compounds represented by formula (I) wherein k, j, Q, R1, R2a, R2b, R2c, R2d, R3a, R3b, R3c, and R3d are as defined herein. after, as stereoisomer, enantiomer, tautomer or mixtures thereof; or a pharmaceutically acceptable salt, solvent or prodrug thereof, which is useful for the treatment and / or prevention of sodium channel mediated diseases or conditions, such as pain. The invention also relates to pharmaceutical compositions containing these compounds and to processes for the preparation and use of said compounds.
Term
No projected expiry on record.
- Priority
- Filed
- Granted
- Today
4 priority claims, no other members on record
Priority claims4
| Document | Office | Kind | Date |
|---|---|---|---|
| 67089605 | United States of America | P | |
| 67089605 | United States of America | P | |
| 60670896 | – | – | – |
| US20050670896P | – | – | – |
Numbers
- Publication, DOCDB
- 29684
- Publication, EPODOC
- MA29684
- Application
- 30344
- Application, DOCDB
- 30344
- Application, EPODOC
- MA20070030344
Titles2
- English
- SPIRO-OXINDOLE COMPOUNDS AND USES THEREOF AS THERAPEUTIC AGENTS
- French
- COMPOSES DE SPIRO-OXINDOLE ET UTILISATIONS ASSOCIEES EN TANT QU'AGENTS THERAPEUTIQUES
Classification
- CPC, 33
- C07D491/10
- A61K31/407
- A61P1/04
- A61P3/10
- A61P3/12
- A61P11/00
- A61P5/14
- A61P13/10
- A61P5/24
- A61P17/02
- A61P9/00
- A61P19/02
- A61P9/06
- A61P21/00
- A61P9/10
- A61P21/02
- A61P21/04
- A61P25/00
- A61P25/02
- A61P25/04
- A61P25/06
- A61P25/08
- A61P25/18
- A61P25/20
- A61P25/22
- A61P25/24
- A61P25/28
- A61P29/00
- A61P35/00
- A61P43/00
- A61K31/36
- A61K31/343
- C07D491/20